Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Novel hypoglycemic compounds designed at RPR

March 3, 1999

SomatoKine reduces insulin use, improves glycemic control in type I diabetes

March 3, 1999

Milestone achieved in Warner-Lambert/Unigene collaboration for oral calcitonin product

March 3, 1999

Naturally occurring inhibitors of cathepsins discovered at Sankyo

March 2, 1999

Agents for diabetes, impotence, lipid and cardiovascular disorders from Fujisawa

March 2, 1999

Lilly introduces new insulin dosing forms with improved convenience

March 1, 1999

Novo Nordisk discloses new potassium channel modulators and use in endocrine and other disorders

March 1, 1999

Schering-Plough initiates manufacture of Vasomax

March 1, 1999

Muse granted marketing approval in Germany

Feb. 26, 1999

Cortecs concludes phase III Macritonin trial

Feb. 26, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...